Medical Equipment

Cardiovascular Calcification Global Forecast: Market to Scale Up to $2.78 Billion by 2030 at 7.9% CAGR

March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cardiovascular calcification market from 2026–2035 with trusted insights from The Business Research Company

How much is the Cardiovascular Calcification Market valued at in 2026, and what valuation is forecast for 2030?

The cardiovascular calcification market has shown robust growth recently. It is anticipated to expand from $1.9 billion in 2025 to $2.05 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.7%. This historical growth can be linked to factors like an aging population, the increasing prevalence of cardiovascular diseases, the expansion of diagnostic imaging infrastructure, a rise in the use of CT and MRI systems, and greater awareness of vascular calcification risks.

The cardiovascular calcification market is anticipated to show significant expansion in the next few years, with its size forecast to reach $2.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. This growth during the projected period stems from factors such as increasing demand for precise cardiovascular diagnostics, the rising adoption of AI-assisted imaging analysis, the broadening of minimally invasive diagnostic procedures, growing investments in preventive cardiology, and an increasing focus on early intervention strategies. Key trends for the forecast period include the increasing uptake of advanced cardiovascular imaging modalities, a rising use of calcium scoring and risk stratification tools, the growing integration of AI in diagnostic imaging, the expansion of catheter-based diagnostic technologies, and an enhanced focus on early disease detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33053&type=smp

What Drivers Are Influencing The Growth Of The Cardiovascular Calcification Market?

An anticipated increase in cardiovascular disease prevalence is set to drive the expansion of the cardiovascular calcification market in the future. These diseases are health issues that harm the heart and blood vessels, resulting in conditions like heart disease, strokes, and elevated blood pressure. The increase in cardiovascular ailments stems from inactive lifestyles and unhealthy eating patterns, intensifying dangers such as high blood pressure, excessive weight, and harm to arteries. Cardiovascular calcification plays a role in managing cardiovascular diseases by acting as an indicator of atherosclerosis and plaque accumulation, facilitating the prompt identification of heart and vessel damage and informing preventative or treatment strategies. As an illustration, in August 2025, data from the National Institutes of Health, a US-based government agency, indicated that from 2025 to 2050, cardiovascular prevalence is forecast to climb by 90%, mortality by 73%, and DALYs by 55%, with fatalities growing from 20.5 million to 35.6 million. Consequently, the growing number of cardiovascular diseases is fueling the expansion of the cardiovascular calcification market.

How Is The Cardiovascular Calcification Market Organized Into Various Segments?

The cardiovascular calcification market covered in this report is segmented –

1) By Product Type: Imaging Systems; Atherectomy Devices; Stents; Transcatheter Valves

2) By Diagnosis: Computed Tomography (CT) Calcium Scoring; Echocardiography; Intravascular Ultrasound; Biomarkers

3) By Application: Coronary Artery Disease; Aortic Valve Stenosis; Peripheral Artery Disease; Chronic Kidney Disease (CKD) Related Vascular Calcification

4) By End User: Hospitals; Ambulatory Surgical Centers; Cardiac Clinics; Dialysis And Nephrology Centers

Subsegments:

1) By Imaging Systems: Magnetic Resonance Imaging; Computed Tomography Imaging; Ultrasound Imaging; Nuclear Imaging

2) By Atherectomy Devices: Rotational Atherectomy Devices; Directional Atherectomy Devices; Orbital Atherectomy Devices; Laser Atherectomy Devices

3) By Stents: Drug Eluting Stents; Bare Metal Stents; Bioabsorbable Stents; Balloon Expandable Stents

4) By Transcatheter Valves: Transcatheter Aortic Valves; Transcatheter Mitral Valves; Transcatheter Pulmonary Valves; Transcatheter Tricuspid Valves

Which Trends Are Expected To Influence The Cardiovascular Calcification Market In The Upcoming Years?

Leading companies in the cardiovascular calcification market are concentrating on developing innovative solutions, such as targeted intravascular shockwave energy delivery technology, with the aim of improving the treatment of heavily calcified lesions through enhanced lesion crossing, vessel compliance, and procedural success rates. This targeted intravascular shockwave energy delivery technology is a catheter-based therapy designed to emit controlled acoustic pressure waves within blood vessels, fracturing calcified plaque while preserving surrounding soft tissue and vessel integrity. For instance, in March 2025, Shockwave Medical Inc., a US-based medical device company, introduced a novel forward intravascular lithotripsy platform in the US, intending to transform the treatment of difficult-to-cross calcified lesions. This platform utilizes forward sonic pressure waves to fracture calcium in challenging calcified peripheral artery lesions without requiring balloon inflation. Its purpose is to enable safe catheter advancement and vessel modification in complex peripheral artery disease (PAD) cases like CLTI, thereby improving outcomes compared to traditional tools. Key advantages, as shown in FORWARD PAD trial data, include 99% technical success, minimal complications (1.1% major events), reduced risks of perforation or embolization, and enhanced efficiency for below-the-knee treatments.

Who Are The Primary Competitors In The Global Cardiovascular Calcification Market?

Major companies operating in the cardiovascular calcification market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Royal Philips Healthcare, GE HealthCare Technologies Inc., Boston Scientific Corporation, Shimadzu Corporation, HeartFlow Inc., Aidoc Ltd., Neusoft Medical Systems Co. Ltd., Medis Medical Imaging Systems B.V., Pie Medical Imaging B.V., Canon Medical Systems Corporation, Keya Medical Technology Co. Ltd., Coreline Soft Co. Ltd., FastWave Medical Inc., Cleerly Inc., United Imaging Healthcare Co. Ltd., Zebra Medical Vision Ltd., Circle Cardiovascular Imaging Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cardiovascular-calcification-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Cardiovascular Calcification Market?

North America was the largest region in the cardiovascular calcification market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular calcification market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cardiovascular Calcification Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33053&type=smp

Browse Through More Reports Similar to the Global Cardiovascular Calcification Market 2026, By The Business Research Company

Cardiovascular Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-health-supplements-global-market-report

Cardiovascular Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-clinical-trials-global-market-report

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795